EmboCept® S DSM 50 µm Effective short-term chemoembolization
EmboCept®S is mentioned in the CIRSE Guideline (Lucatelli et al. 2021) for chemoembolization of inoperable liver and lung tumors (DSM-TACE).
Product Overview
EmboCept® S DSM 50 µm microspheres are an adjuvant in the intra-arterial treatment of inoperable liver and lung tumors and used in combination with cytostatic agents.
EmboCept® S DSM 50 µm
- Simple application.
- Well tolerated.
- Boosts tumor necrosis due to temporary ischemia.
- Preserves function of target organ over time.
- Degradability of DSM allows vascular reperfusion after ca. 90 minutes.
- Can be combined with any chemotherapeutic drug.
- Repeated applications possible at short intervals.
Calibrated Spheres for Optimal Vessel Occlusion
A first-in-class medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures. SmartPAN is approved for commercialization in Europe (CE marked).
SmartPAN® characteristics
- Medium-sized DSM mixed with water and pH indicator bromothymol blue to form Gelspheres.
- Detection of pancreatic fluid leakage during open/minimally invasive surgical procedures.
- Bromothymol blue indicates leakage of alkaline pancreatic fluid by color change during surgery.
SmartPAN®
- Visualizes pancreatic leakage immediately on contact with pancreatic fluid.
- Applied easily to the surgical closure site and generates highly visible color indication when in contact with pancreatic fluid,
indicating leakage. - Gives the surgeon confidence that
no pancreatic fluid is leakging at
time of surgery completion. - Delivered as a sterile pre-packed
syringe, ready to use.
